<DOC>
	<DOCNO>NCT00774449</DOCNO>
	<brief_summary>Chronic organ dysfunction lung transplantation ( BOS ) common cause death long-term survivor lung transplantation refractory intervention . Early marker establish project study overcome problem disease recognition impairment graft function already take place . Long-term longitudinal monitoring stable recipient innovative marker airway inflammation ventilation new image technique define different entity chronic organ dysfunction LTx . A database specimen service unit project create . Hypothesis : This project reveal new marker image tool recipient develop BOS lung transplantation . These tool allow early diagnosis accurate monitoring disease process . Different pattern disease characterize .</brief_summary>
	<brief_title>Characterization Bronchiolitis-obliterans Syndrome ( BOS ) Following Lung Transplantation</brief_title>
	<detailed_description>Chronic organ dysfunction lung allograft common cause death lung transplant recipient first postoperative year major cause morbidity long-term care . It affect every second recipient survive 5 year transplantation ( Boehler , Estenne 2003 ) . Obliterative bronchiolitis ( OB ) histo-pathological process underlie chronic organ dysfunction LTx . Bronchiolitis obliterans syndrome ( BOS ) clinical definition chronic organ dysfunction follow lung transplantation ( LTx ) refers progressive obstructive ventilatory disorder . Staging perform accord baseline value force expiratory volume LTx ( Estenne et al . 2001 ) . Excessive immunosuppression may deleterious increase risk infection , thereby trigger innate adaptive immunity . BOS progressive case stabilisation . Different clinical entity find accord time onset , speed decline graft function ( Jackson et al . 2002 ) , ventilatory pattern , finding image study ( Pakhale et al 2005 , Choi et al 2003 ) response macrolides ( Gerhardt et al . 2003 ) . Exhaled biomarkers promise marker disease activity pat BOS ( Muylem 2007 , Brugiere et al 2005 ) Alloimmune-independent -dependent mechanism produce injury inflammation epithelial cell subepithelial structure , lead aberrant tissue repair ( Nicod et al 2006 ) . The trigger innate immunity various infection ( especially respiratory virus , Khalifah et al 2004 ) chemical injury ( e.g . gastroesophageal reflux aspiration , Palmer et al . 2000 ) , may lead release danger signal able activate dendritic cell , crucial link adaptive immunity . Inflammation also increase expression display major histocompatibility alloantigens thus favor initiation rejection episode . The injury evoke proinflammatory response cellular infiltration lead excessive fibroproliferation result matrix deposition vascular remodelling . These phenomenon may limited time location may protract . Reducing risk alloimmune-independent factor may important treat acute episode lung rejection . Newpotential therapeutic target emerge research perform leukotriene receptor , chemokine receptor , growth factor . Neutralizing molecule may reduce initial mononuclear polynuclear infiltrate subsequent fibroproliferative process neovascular change , feed process . ( Nicod 2006 ) . Macrolides promise new agent partially reverse loss graft function subgroup patient , may change definition BOS near future ( Gerhardt et al 2003 ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<criteria>Individuals , undergone double ( DLTx ) heart lung transplantation ( HLTx ) Hannover Medical School 6 month prior inclusion Ages : 18 68 Years Gender : Stable graft function ( FEV1 &gt; 90 % baseline ) Severe airway complication surgery necessitate repeat intervention last 3 month Need supplemental oxygen time inclusion Single lung ( SLTx ) live lobar recipient Established diagnosis BOS time inclusion Inability undergo bodyphlethysmography e.g . due persistent infection multidrug resistant bacteria ( MRSA , VRE , Burkholderia Cepacia , Pandorea )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>lung transplantation</keyword>
	<keyword>bronchiolitis obliterans syndrome</keyword>
	<keyword>broncholaveolar lavage</keyword>
	<keyword>high-resolution computertomography</keyword>
	<keyword>quality life</keyword>
</DOC>